Tower Research Capital (TRC)’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-103
| Closed | -$1.36K | – | 6199 |
|
|
2024
Q1 | $1.36K | Buy |
+103
| New | +$1.49K | ﹤0.01% | 5276 |
|
|
2023
Q4 | – | Sell |
-41
| Closed | -$615 | – | 6400 |
|
|
2023
Q3 | $615 | Buy |
41
+33
| +413% | +$497 | ﹤0.01% | 5520 |
|
|
2023
Q2 | $104 | Sell |
8
-585
| -99% | -$6.95K | ﹤0.01% | 5817 |
|
|
2023
Q1 | $7K | Buy |
593
+310
| +110% | +$5.15K | ﹤0.01% | 4806 |
|
|
2022
Q4 | $4K | Sell |
283
-478
| -63% | -$5.57K | ﹤0.01% | 5127 |
|
|
2022
Q3 | $5K | Sell |
761
-601
| -44% | -$5.03K | ﹤0.01% | 5203 |
|
|
2022
Q2 | $13K | Buy |
1,362
+1,333
| +4,597% | +$23.7K | ﹤0.01% | 4253 |
|
|
2022
Q1 | $1K | Buy |
+29
| New | +$1.14K | ﹤0.01% | 5955 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6804 |
|
|
2021
Q3 | – | Sell |
-5
| Closed | -$415 | – | 6374 |
|
|
2021
Q2 | $0 | Buy |
+5
| New | +$437 | ﹤0.01% | 6028 |
|
|
2021
Q1 | – | Sell |
-353
| Closed | -$29K | – | 5866 |
|
|
2020
Q4 | $29K | Buy |
353
+341
| +2,842% | +$31.4K | ﹤0.01% | 3609 |
|
|
2020
Q3 | $1K | Buy |
+12
| New | +$905 | ﹤0.01% | 4760 |
|
|
2019
Q4 | – | Sell |
-95
| Closed | -$33K | – | 4618 |
|
|
2019
Q3 | $33K | Buy |
+95
| New | +$51.6K | ﹤0.01% | 2116 |
|
|
2019
Q2 | – | Sell |
-13
| Closed | -$20K | – | 4498 |
|
|
2019
Q1 | $20K | Buy |
13
+10
| +333% | +$18K | ﹤0.01% | 2281 |
|
|
2018
Q4 | $5K | Sell |
3
-4
| -57% | -$8.7K | ﹤0.01% | 2961 |
|
|
2018
Q3 | $16K | Buy |
+7
| New | +$21.7K | ﹤0.01% | 2497 |
|
|
2018
Q2 | – | Sell |
-7
| Closed | -$21K | – | 4203 |
|
|
2018
Q1 | $21K | Sell |
7
-5
| -42% | -$15K | ﹤0.01% | 2154 |
|
|
2017
Q4 | $30K | Buy |
12
+3
| +33% | +$8.53K | ﹤0.01% | 1748 |
|
|
2017
Q3 | $25K | Buy |
+9
| New | +$23.7K | ﹤0.01% | 2596 |
|
|
2017
Q2 | – | Sell |
-13
| Closed | -$34K | – | 3642 |
|
|
2017
Q1 | $34K | Sell |
13
-39
| -75% | -$112K | ﹤0.01% | 956 |
|
|
2016
Q4 | $119K | Buy |
+52
| New | +$124K | 0.01% | 876 |
|
|
2016
Q3 | – | Sell |
-25
| Closed | -$78K | – | 4684 |
|
|
2016
Q2 | $78K | Buy |
25
+24
| +2,400% | +$78.1K | 0.01% | 1265 |
|
|
2016
Q1 | $2K | Sell |
1
-1
| -50% | -$4.15K | ﹤0.01% | 3488 |
|
|
2015
Q4 | $9K | Buy |
+2
| New | +$8.74K | ﹤0.01% | 2317 |
|
|
2015
Q3 | – | Sell |
-24
| Closed | -$93.1K | – | 3714 |
|
|
2015
Q2 | $96K | Sell |
24
-10
| -29% | -$38.6K | 0.01% | 886 |
|
|
2015
Q1 | $136K | Buy |
34
+25
| +278% | +$115K | 0.02% | 654 |
|
|
2014
Q4 | $42K | Sell |
9
-30
| -77% | -$129K | ﹤0.01% | 1133 |
|
|
2014
Q3 | $158K | Buy |
+39
| New | +$146K | 0.02% | 630 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 4781 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5078 |
|
|
2013
Q4 | – | Sell |
-23
| Closed | -$89.7K | – | 4282 |
|
|
2013
Q3 | $93K | Buy |
23
+16
| +229% | +$68.9K | 0.01% | 1367 |
|
|
2013
Q2 | $26K | Buy |
+7
| New | +$28.8K | ﹤0.01% | 1480 |
|
Other funds holding ACOR
Tower Research Capital (TRC)'s ACOR Position: Q2 2024 in Review
Tower Research Capital (TRC) sold out of Acorda Therapeutics (ACOR) in Q2 2024, closing a stake of 103 shares — an estimated $1.36K sold.
Tower Research Capital (TRC) first reported a position in ACOR in Q2 2013 and held it in 29 quarters. The position peaked at $158K in Q3 2014. 2 funds tracked by Wall St. Rank hold ACOR as of Q2 2024.
- Tower Research Capital (TRC) reported no remaining Acorda Therapeutics position as of Q2 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 103 Acorda Therapeutics shares in Q2 2024, an estimated $1.36K.
- Tower Research Capital (TRC) first reported a position in Acorda Therapeutics in Q2 2013 and held it in 29 quarters.
- Tower Research Capital (TRC)'s Acorda Therapeutics position peaked at $158K in Q3 2014.
- 2 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.